semaglutide pediatric mechanism
Cut Adolescents’ BMI 7% With Semaglutide
Semaglutide reduces adolescent BMI by 7% by activating GLP-1 receptors that curb appetite and improve insulin sensitivity, offering a steady weekly dose that fits the rapid growth phase of teenagers. In clinical trials, the drug’s prolonged action aligns with puberty-driven hormonal swings, delivering weight loss without compromising growth. The